Zenith Healthcare Ltd (BSE: 530665) is an Ahmedabad, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹18 Cr, it ranks #4,479 by market cap among the 6,197 Indian listed companies on FinBizNet, and #23 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹3.45 (as of 16 Nov 2026), the share price is 49.8% below its 52-week high of ₹6.87 and 42.6% above its 52-week low of ₹2.42. The share price is down 24.5% over one year and up 3.8% over three months.
| Current Price | ₹3.45 |
|---|---|
| Market Cap | ₹18 Cr |
| BSE Code | 530665 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 3,450 |
| Return on Equity | 0.13% |
| Return on Assets | -1.98% |
| 52-Week Range | ₹2.42 – ₹6.87 |
| 1-Year Price Change | -24.5% |
| 3-Month Price Change | +3.8% |
| Beta (1Y) | 0.48 |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.zenithhealthcare.com |
| Revenue | ₹3 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 4.1% |
| EPS (Basic) | ₹0.03 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Zenith Healthcare Ltd reported revenue of ₹3 Cr in Q1 FY27, up 8.9% from ₹3 Cr in Q1 FY26 and up 30.9% from ₹3 Cr in Q4 FY26. It posted a net profit of ₹0 Cr for the quarter, against a net loss of ₹0 Cr in Q1 FY26. Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹2 Cr (Q2 FY26) to ₹3 Cr (Q1 FY27). The company reported a net loss in 3 of these 8 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q1 FY27 | ₹3 Cr | ₹0 Cr | 4.1% |
| Q4 FY26 | ₹3 Cr | −₹0 Cr | −13.0% |
| Q3 FY26 | ₹2 Cr | ₹0 Cr | 8.9% |
| Q2 FY26 | ₹2 Cr | ₹0 Cr | 6.2% |
| Q1 FY26 | ₹3 Cr | −₹0 Cr | −0.6% |
| Q4 FY25 | ₹3 Cr | ₹0 Cr | 3.2% |
| Q3 FY25 | ₹2 Cr | −₹0 Cr | −12.6% |
| Q2 FY25 | ₹3 Cr | ₹0 Cr | 3.0% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 45.54% of Zenith Healthcare Ltd's shares as of Mar 2026, unchanged from Mar 2025. Delivery averaged 79.7% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Zenith Healthcare Limited manufactures and markets pharmaceutical formulations in India. It offers its products in the form of tablets, capsules, oral liquids, and injectable. The company also engages in the contract manufacturing of various dosage forms. It supplies medicines to Cambodia, Myanmar, Papa New Guinea, Sri Lanka, Kenya, Nigeria, Gambia, Zambia, Namibia, Botswana, Armenia, Georgia, Uzbekistan, Paraguay, Bolivia, Venezuela, Guatemala, Barbados, Jamaica, Bahamas, Yemen, and Turkey. Zenith Healthcare Limited was incorporated in 1994 and is based in Ahmedabad, India.
1. Manufacturing of Pharmaceutical Formulations-This segment manufactures pharmaceutical formulations in the forms of tablets, capsules, oral liquid, and injectables.
1. Manufacture and Marketing of Pharmaceutical Formulations-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 16.98% | ₹4,979 Cr | +30.4% |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.81% | ₹347 Cr | +127.8% |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.36% | ₹682 Cr | +64.0% |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.49% | ₹610 Cr | +15.4% |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | n/m | -0.63% | ₹417 Cr | +22.1% |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.88% | ₹195 Cr | — |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.54% | ₹32 Cr | — |
| Trident Lifeline Limited | ₹511 Cr | 26 | — | — | +37.6% |
| Zenith Healthcare Ltd | ₹18 Cr | 3,450 | 0.13% | ₹3 Cr | -24.5% |
Listed by market capitalisation. Ratios are shown for context only.
Zenith Healthcare Ltd is trading at ₹3.45, with a market capitalisation of ₹18 Cr.
Zenith Healthcare Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Zenith Healthcare Ltd has a P/E of 3,450 and a return on equity of 0.13%.
Zenith Healthcare Ltd is listed on the BSE under the scrip code 530665.
Zenith Healthcare Ltd's share price is down 24.5% over one year and up 3.8% over three months. Its 52-week range is ₹2.42 to ₹6.87.
In Q1 FY27, Zenith Healthcare Ltd reported revenue of ₹3 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.03 (standalone, parsed from the company's exchange filing).
Zenith Healthcare Ltd reported revenue of ₹3 Cr in Q1 FY27, up 8.9% from ₹3 Cr in Q1 FY26 and up 30.9% from ₹3 Cr in Q4 FY26.
Promoters held 45.54% of Zenith Healthcare Ltd's shares as of Mar 2026, unchanged from Mar 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.